Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 2, 2016, Pages S77-S81

  Krishan, Saini ^a  

^a Sanjivani College of Pharmaceutical Science   (India)

Author keywords

Dyslipideamia; Metabolic disorders; NAFLD; Ultrasound sonography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; HEMOGLOBIN; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; DIAGNOSTIC IMAGING; DYSLIPIDEMIAS; METABOLIC DISEASES; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SEX DIFFERENCE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SEX FACTORS;

EID: 85027921374     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.01.034     Document Type: Article

References (33)

1. Lopez-velazquez, Jorge A., et al. The prevalence of nonalcoholic fatty liver disease in the Americas. Ann Hepatol 13:2 (2014), 166–178 March–April.
2. Ludwig, J., Viaggiano, T.R., McGill, D.B., Oh, B.J., Nonalcoholic steatohepatitis: Mayo clinic experience with an hitherto unnamed disease. Mayo Clin Proc 55 (1980), 434–438.
3. Adler, M., Schaffner, F., Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67 (1979), 811–816.
4. Capron, J.-P., et al. Fasting in obesity: another cause of liver injury with alcoholic hyaline?. Dig Dis Sci 27 (1982), 265–268.
5. Itoh, S., Yougel, T., Kawagoe, K., Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82 (1987), 650–654.
6. Diehl, A.M., Goodman, Z., Ishak, K.G., Alcohol-like liver disease in non-alcoholics: a clinical and histologic comparison with alcohol-induced liver disease. Gastroenterology 95 (1988), 1056–1062.
7. Lee, R.G., Non-alcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20 (1989), 594–598.
8. Wanless, I.R., Lentz, J.S., Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990), 1106–1110.
9. Powell, E.E., Hanson, R., et al. The natural history of non-alcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11 (1990), 74–80.
10. Fiatarone, J.R., Coverdale, S.A., Batey, R.G., Farrell, G.C., Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. Gastroenterol Hepatol 6 (1991), 585–590.
11. Bacon, B.R., Farahvash, M.J., Janney, C.G., NeuschwanderTetri, B.A., Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107 (1994), 1103–1109.
12. Marchesini, G., Forlani, G., NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 35 (2002), 497–499.
13. Matteoni, C.A., Younossi, Z.M., Gramlich, T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999), 1413–1419.
14. Angulo, P., Non-alcoholic fatty liver disease. N Engl J Med 16 (2002), 1221–1231.
15. Younossi, Z.M., Diehl, A.M., Ong, J.P., Non-alcoholic fatty liver disease: an agenda for clinical research. Hepatology 35 (2002), 746–752.
16. Farrell, G.C., Okuda, Lecture, Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region. J Gastroenterol Hepatol 18 (2003), 124–138.
17. Neuschwander-Tetri, B.A., Caldwell, S.H., Non-alcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37 (2003), 1202–1219.
18. World Health Organization, Preventing and managing the global epidemic: report of a WHO consultation. WHO Technical Report Series, vol. 894, 2000, World Health Organization.
19. Mokdad, A.H., Ford, E.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 289 (2003), 76–79.
20. Marceau, P., Biron, S., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84 (1999), 1513–1517.
21. Ratziu, V., Giral, P., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000), 1117–1123.
22. Dixon, J.B., Bhathal, P.S., O'Brien, P.E., Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001), 91–100.
23. Pagano, G., Pacini, G., et al. Non-alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35 (2002), 367–372.
24. Wanless, I.R., Lentz, J.S., Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990), 1106–1110.
25. Brunt, E.M., Non-alcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 (2001), 3–16.
26. Brunt, E.M., Ramrakhiani, S., et al. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 16 (2003), 49–56.
27. Teli, M.R., James, O.F., et al. The natural history of non-alcoholic fatty liver: a follow-up study. Hepatology 22 (1995), 1714–1719.
28. Hourigan, L.F., Macdonald, G.A., et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29 (1999), 1215–1219.
29. Luxmi, Shobha, Abdul Sattar, Rukhsana, Ara, Jamal, Association of non alcoholic fatty liver with type 2 diabetes mellitus. JLUMHS(September–December), 2008, 188–193.
30. chatrath, Hemant, Vuppalanchi, Raj, Chalasani, Naga, Dyslipidemia in patients with nonalcoholic fatty liver disease. Pubmad(5), 1999, 156–172 June 2.
31. Liberopoulos, E.N., Athyros, V.G., Elisaf, M.S., Mikhailidis, D.P., Statins for non-alcoholic fatty liver disease: a new indication?. Aliment Pharmacol Ther 24:4 (2006), 698–699.
32. Alina Dima, A.G., Marinescu, Dima, A.C., Non-alcoholic fatty liver disease and the statins treatment. Rom J Intern Med 50:1 (2012), 19–25.
33. Shams, Mohamed E.E., Al-Gayyar, Mohammed M.H., Barakat, Andenaase A.M.E., Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines. Sci Pharm 79 (2011), 623–634.